

| Catalog No. | HB189014 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Species reactivity | Human, Mouse, Rat | ||||||||
| Applications | ELISA, IHC, WB | ||||||||
| Host species | Rabbit | ||||||||
| Isotype | IgG | ||||||||
| Clonality | Polyclonal | ||||||||
| Immunogen | E. coli - derived recombinant Human NOS3 (Arg756-Gly1161). | ||||||||
| Target | Constitutive NOS, NOSIII, eNOS, Endothelial NOS, EC-NOS, Nitric oxide synthase, endothelial, NOS type III, NOS3, cNOS | ||||||||
| Purification | Purified by antigen affinity column. | ||||||||
| Accession | P29474 | ||||||||
| Form | Liquid | ||||||||
| Storage buffer | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
||||||||
| Product Usage Information |
| ||||||||
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. | ||||||||
| Background | Nitric oxide synthase 3 (NOS3) is a ~133 kDa protein. Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets. 1. Janssens, SP. et al. (1992) The Journal of biological chemistry 267, 14519-22. PMID: 1378832 | ||||||||
| Note | For research use only. |

Western blot analysis was performed using anti-NOS3 polyclonal antibody at 1ug/mL on recombinant NOS3 (Catalog No. HB189022).
Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com


+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский